Clinical Trials Browser

Completed × INDUSTRY × VT-464 × Clear all

NCT02361086 2019-02-01

A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

Phase 1/2 Completed

Castration-resistant Prostate Cancer

NCT02130700 2018-05-07

Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer

Phase 2 Completed

Neoplasm Metastasis, Prostatic Neoplasms